BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38795936)

  • 1. Candida auris - Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing - A single centre experience.
    Patwardhan SA; Prayag PS; Soman RN; Purandare BD; Ramya S; Dawra R; Joshi R; Prayag AP
    Indian J Med Microbiol; 2024 May; 50():100618. PubMed ID: 38795936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
    Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
    Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of Sensititre YeastOne and VITEK 2 against the Clinical and Laboratory Standards Institute M27-E4 reference broth microdilution method for the antifungal susceptibility testing of Cryptococcus neoformans and Cryptococcus gattii.
    Zhang M; Zhou Z; Wang D; Zhou A; Song G; Chen X; Guo J; Wu W
    Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35099022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.
    Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J
    Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Vitek identification and antifungal susceptibility testing methods to DNA sequencing and Sensititre YeastOne antifungal testing.
    Vijgen S; Nys S; Naesens R; Magerman K; Boel A; Cartuyvels R
    Med Mycol; 2011 Jan; 49(1):107-10. PubMed ID: 20560861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common
    Lim HJ; Shin JH; Kim MN; Yong D; Byun SA; Choi MJ; Lee SY; Won EJ; Kee SJ; Kim SH; Shin MG
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32900684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Vitek 2 system for antifungal susceptibility testing of
    Siopi M; Pachoulis I; Leventaki S; Spruijtenburg B; Meis JF; Pournaras S; Vrioni G; Tsakris A; Meletiadis J
    J Clin Microbiol; 2024 Apr; 62(4):e0152823. PubMed ID: 38501836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Six Antifungal Susceptibilities of 11
    Lee H; Choi SH; Oh J; Koo J; Lee HJ; Cho SI; Shin JH; Lee HK; Kim SY; Lee CH; Kim YR; Sohn YH; Kim WJ; Ryu SW; Sung GH; Kim J
    Microbiol Spectr; 2022 Apr; 10(2):e0125321. PubMed ID: 35384691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of Sensititre YeastOne and Micronaut-AM EUCAST for antifungal susceptibility testing in candidaemia isolates.
    Bélik F; Deckers C; Khourssaji M; Huang TD; Denis O; Montesinos I
    J Mycol Med; 2024 Mar; 34(1):101465. PubMed ID: 38401236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of antifungal susceptibility testing methods for clinical Candida albicans isolates.
    Tan XT; Mohd Shuhairi NB; Mohd Tap R; Amran F
    Indian J Med Microbiol; 2024 Jul; 50():100663. PubMed ID: 38964501
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
    Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candidaspp.
    Altinbaş R; Barış A; Şen S; Öztürk R; Kiraz N
    Turk J Med Sci; 2020 Dec; 50(8):2024-2031. PubMed ID: 32659879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species.
    Dalyan Cilo B; Ener B
    Cureus; 2021 Dec; 13(12):e20220. PubMed ID: 35004039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.
    Espinel-Ingroff A; Alvarez-Fernandez M; Cantón E; Carver PL; Chen SC; Eschenauer G; Getsinger DL; Gonzalez GM; Govender NP; Grancini A; Hanson KE; Kidd SE; Klinker K; Kubin CJ; Kus JV; Lockhart SR; Meletiadis J; Morris AJ; Pelaez T; Quindós G; Rodriguez-Iglesias M; Sánchez-Reus F; Shoham S; Wengenack NL; Borrell Solé N; Echeverria J; Esperalba J; Gómez-G de la Pedrosa E; García García I; Linares MJ; Marco F; Merino P; Pemán J; Pérez Del Molino L; Roselló Mayans E; Rubio Calvo C; Ruiz Pérez de Pipaon M; Yagüe G; Garcia-Effron G; Guinea J; Perlin DS; Sanguinetti M; Shields R; Turnidge J
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6725-32. PubMed ID: 26282428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against
    Melhem MSC; Coelho VC; Fonseca CA; Oliveira L; Bonfietti LX; Szeszs MW; Magri MMC; Dorneles FS; Taguchi H; Moreira DVS; Motta AL; Batista MV; Kamei K; Shikanai-Yasuda MA
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two commercial methods for the susceptibility testing of Candida species: Vitek 2
    Siqueira RA; Doi AM; de Petrus Crossara PP; Koga PCM; Marques AG; Nunes FG; Pasternak J; Martino MDV
    Rev Iberoam Micol; 2018; 35(2):83-87. PubMed ID: 29580699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.